Correction to: A1R–A2AR heteromers coupled to Gs and Gi/0 proteins modulate GABA transport into astrocytes (Purinergic Signalling, (2013), 9, 3, (433-449), 10.1007/s11302-013-9364-5);A1R-A2AR heteromers coupled to Gs and Gi/0 proteins modulate GABA transport into astrocytes

Purinergic Signalling

Volumn 9, Issue 3, 2013, Pages 433-449

  Cristóvão Ferreira, Sofia ^a,b   Navarro, Gemma ^c   Brugarolas, Marc ^c   Pérez Capote, Kamil ^c   Vaz, Sandra H ^a,b   Fattorini, Giorgia ^d,e   Conti, Fiorenzo ^d,e   Lluis, Carmen ^c   Ribeiro, Joaquim A ^a,b   McCormick, Peter J ^c   Casadó, Vicent ^c   Franco, Rafael ^c,f   Sebastião, Ana M ^a,b  

^a INSTITUTO DE MEDICINA MOLECULAR   (Portugal)

^b UNIVERSITY OF LISBON   (Portugal)

^c UNIVERSITY OF BARCELONA   (Spain)

^d UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

^e INRCA   (Italy)

^f UNIVERSITY OF NAVARRA   (Spain)

Author keywords

Adenosine heteromers; Astrocytes; G protein coupling; GABA transporters

Indexed keywords

2 [4 (2 CARBOXYETHYL) PHENETHYLAMINO] ADENOSINE 5' (N ETHYLCARBOXAMIDE); 4 AMINOBUTYRIC ACID CARRIER; 5 AMINO 2 (2 FURYL) 7 (2 PHENYLETHYL) PYRAZOLO [4, 3 E] [1, 2, 4] TRIAZOLO [1, 5 C] PYRIMIDINE; 6 N CYCLOPENTYLADENOSINE; 8 CYCLOPENTYL 1, 3 DIPROPYLXANTHINE; ADENOSINE A1 RECEPTOR; ADENOSINE A2A RECEPTOR; ADENOSINE A2B RECEPTOR; ADENOSINE A3 RECEPTOR; GUANINE NUCLEOTIDE BINDING PROTEIN; GUANINE NUCLEOTIDE BINDING PROTEIN GI SUBUNIT; GUANINE NUCLEOTIDE BINDING PROTEIN GS SUBUNIT; GUANOSINE 5' O (3 THIOTRIPHOSPHATE); SULFUR 35; UNCLASSIFIED DRUG; 4 AMINOBUTYRIC ACID; ADENOSINE; INHIBITORY GUANINE NUCLEOTIDE BINDING PROTEIN; STIMULATORY GUANINE NUCLEOTIDE BINDING PROTEIN;

4 AMINOBUTYRIC ACID UPTAKE; ARTICLE; ASTROCYTE; BIOLUMINESCENCE RESONANCE ENERGY TRANSFER; BIOTINYLATION; GENETIC TRANSFECTION; IMMUNOCYTOCHEMISTRY; RADIOASSAY; WESTERN BLOTTING; ANIMAL; FEMALE; HEK293 CELL LINE; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; METABOLISM; PHYSIOLOGY; RAT; SYNAPTIC TRANSMISSION; WISTAR RAT; CELL STRAIN HEK293;

ADENOSINE; ANIMALS; ASTROCYTES; BLOTTING, WESTERN; FEMALE; GABA PLASMA MEMBRANE TRANSPORT PROTEINS; GAMMA-AMINOBUTYRIC ACID; GTP-BINDING PROTEIN ALPHA SUBUNITS, GI-GO; GTP-BINDING PROTEIN ALPHA SUBUNITS, GS; HEK293 CELLS; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; RADIOLIGAND ASSAY; RATS; RATS, WISTAR; RECEPTOR, ADENOSINE A1; RECEPTOR, ADENOSINE A2A; SYNAPTIC TRANSMISSION; TRANSFECTION;

EID: 84883465357     PISSN: 15739538     EISSN: 15739546     Source Type: Journal    
DOI: 10.1007/s11302-024-10012-3     Document Type: Erratum

References (43)

1. Hamilton N, Attwell D (2010) Do astrocytes really exocytose neurotransmitters? Nat Rev Neurosci 11: 227-238.
2. Krnjevic K, Schwartz S (1967) The action of γ-aminobutyric acid on cortical neurons. Exp Brain Res 3: 320-326.
3. Artola A, Singer W (1987) Long-term potentiation and NMDA receptors in rat visual cortex. Nature 330: 649-652.
4. Blatow M, Rozov A, Katona I, Hormuzdi SG, Meyer AH, Whittington MA, Caputi A, Monyer H (2003) A novel network of multipolar bursting interneurons generates theta frequency oscillations in neocortex. Neuron 38: 805-817.
5. Minelli A, Brecha NC, Karschin C, DeBiasi S, Conti F (1995) GAT-1, a high-affinity GABA plasma membrane transporter, is localized to neurons and astroglia in the cerebral cortex. J Neurosci 15: 7734-7746.
6. Minelli A, DeBiasi S, Brecha NC, Conti F (1996) GAT-3, a high affinity GABA plasma membrane transporter, is localized exclusively to astrocytic processes in the cerebral cortex. J Neurosci 16: 6255-6264.
7. Hertz L, Schousboe A (1987) Primary cultures of GABAergic and glutamatergic neurons as model systems to study neurotransmitter functions: I. Differentiated cells. In: Model systems of development and aging of the nervous system. Giacobini E (eds). M Nijhoff Publ Com, Boston, pp 19-31.
8. Fredholm BB, IJzerman AP, Jacobson KA, Klotz KN, Linden J (2001) International Union of Pharmacology. XXV. Nomenclature and classification of adenosine receptors. Pharmacol Rev 53: 527-552.
9. Correia-de-Sá P, Ribeiro JA (1994) Tonic adenosine A2A receptor activation modulates nicotinic autoreceptor function at the neuromuscular junction. Eur J Pharmacol 271: 349-355.
10. Cunha RA, Johansson B, van der Ploeg I, Sebastião AM, Ribeiro JA, Fredholm BB (1994) Evidence for functionally important adenosine A2a receptors in the rat hippocampus. Brain Res 649: 208-216.
11. Lopes LV, Cunha RA, Ribeiro JA (1999) Cross talk between A(1) and A(2A) adenosine receptors in the hippocampus and cortex of young adult and old rats. J Neurophysiol 82: 3196-3203.
12. Sebastião AM, Ribeiro JA (2000) Fine-tuning neuromodulation by adenosine. Trends Pharmacol Sci 21: 341-346.
13. 2A receptor heteromers. J Neurosci 26: 2080-2087.
14. Ferré S, Navarro G, Casadó V, Cortés A, Mallol J, Canela EI, Lluís C, Franco R (2010) G protein-coupled receptor heteromers as new targets for drug development. Prog Mol Biol Transl Sci 91: 41-52.
15. Orru M, Bakešová J, Brugarolas M, Quiroz C, Beaumont V, Goldberg SR, Lluís C, Cortés A, Franco R, Casadó V, Canela EI, Ferré S (2011) Striatal pre- and postsynaptic profile of adenosine A(2A) receptor antagonists. PLoS One 6: e16088.
16. Canals M, Marcellino D, Fanelli F, Ciruela F, de Benedetti P, Goldberg SR, Neve K, Fuxe K, Agnati LF, Woods AS, Ferré S, Lluís C, Bouvier M, Franco R (2003) Adenosine A2A-dopamine D2 receptor-receptor heteromerization: qualitative and quantitative assessment by fluorescence and bioluminescence energy transfer. J Biol Chem 278: 46741-46749.
17. Ciruela F, Burgueño J, Casadó V, Canals M, Marcellino D, Goldberg SR, Bader M, Fuxe K, Agnati LF, Lluis C, Franco R, Ferré S, Woods AS (2004) Combining mass spectrometry and pull-down techniques for the study of receptor heteromerization. Direct epitope-epitope electrostatic interactions between adenosine A2A and dopamine D2 receptors. Anal Chem 76: 5354-5363.
18. Sarrió S, Casadó V, Escriche M, Ciruela F, Mallol J, Canela EI, Lluis C, Franco R (2000) The heat shock cognate protein hsc73 assembles with A(1) adenosine receptors to form functional modules in the cell membrane. Mol Cell Biol 20: 5164-5174.
19. Schröder R, Janssen N, Schmidt J, Kebig A, Merten N, Hennen S, Müller A, Blättermann S, Mohr-Andrä M, Zahn S, Wenzel J, Smith NJ, Gomeza J, Drewke C, Milligan G, Mohr K, Kostenis E (2010) Deconvolution of complex G protein-coupled receptor signaling in live cells using dynamic mass redistribution measurements. Nat Biotechnol 28: 943-949.
20. Vaz SH, Jorgensen TN, Cristovão-Ferreira S, Duflot S, Ribeiro JA, Gether U, Sebastião AM (2011) Brain-derived neurotrophic factor (BDNF) enhances GABA transport by modulating the trafficking of GABA transporter-1 (GAT-1) from the plasma membrane of rat cortical astrocytes. J Biol Chem 286: 40464-40476.
21. Ferrada C, Moreno E, Casadó V, Bongers G, Cortés A, Mallol J, Canela EI, Leurs R, Ferré S, Lluís C, Franco R (2009) Marked changes in signal transduction upon heteromerization of dopamine D1 and histamine H3 receptor. Br J Pharmacol 157: 64-75.
22. Moreno E, Hoffmann H, Gonzalez-Sepúlveda M, Navarro G, Casadó V, Cortés A, Mallol J, Vignes M, McCormick PJ, Canela EI, Lluís C, Moratalla R, Ferré S, Ortiz J, Franco R (2011) Dopamine D1-histamine H3 receptor heteromers provide a selective link to MAPK signaling in GABAergic neurons of the direct striatal pathway. J Biol Chem 286: 5846-5854.
23. Ferré S, Baler R, Bouvier M, Caron MG, Devi LA, Durroux T, Fuxe K, George SR, Javitch JA, Lohse MJ, Mackie K, Milligan G, Pfleger KD, Pin JP, Volkow ND, Waldhoer M, Woods AS, Franco R (2009) Building a new conceptual framework for receptor heteromers. Nat Chem Biol 5: 131-134.
24. Rashid AJ, So CH, Kong MM, Furtak T, El-Ghundi M, Cheng R, O'Dowd BF, George SR (2007) D1-D2 dopamine receptor heterooligomers with unique pharmacology are coupled to rapid activation of Gq/11 in the striatum. Proc Natl Acad Sci USA 104: 654-659.
25. Gill DM, Meren R (1978) ADP-ribosylation of membrane proteins catalyzed by cholera toxin: Basis of the activation of adenylate cyclase. Proc Natl Acad Sci USA 75: 3050-3054.
26. Bokoch GM, Gilman AG (1984) Inhibition of receptor-mediated release of arachidonic acid by pertussis toxin. Cell 39: 301-308.
27. Smith RJ, Sam LM, Justen JM, Bundy GL, Bala GA, Bleasdale JE (1990) Receptor-coupled signal transduction in human polymorphonuclear neutrophils: effects of a novel inhibitor of phospholipase C-dependent processes on cell responsiveness. J Pharmacol Exp Ther 253: 688-697.
28. Wang LY, Salter MW, MacDonald JF (1991) Regulation of kainate receptors by cAMP-dependent protein kinase and phosphatases. Science 253: 1132-1135.
29. Awad JA, Johnson RA, Jakobs KH, Schultz G (1983) Interactions of forskolin and adenylate cyclase. Effects on substrate kinetics and protection against inactivation by heat and N-ethylmaleimide. J Biol Chem 258: 2960-2965.
30. Xiong L, Shuhendler AJ, Rao J (2012) Self-luminescing BRET-FRET near-infrared dots for in vivo lymph-node mapping and tumour imaging. Nat Commun 3: 1193.
31. Jordan BA, Trapaidze N, Gomes I, Nivarthi R, Devi LA (2001) Oligomerization of opioid receptors with beta 2-adrenergic receptors: a role in trafficking and mitogen-activated protein kinase activation. Proc Natl Acad Sci U S A 98: 343-348.
32. Pfeiffer M, Kirscht S, Stumm R, Koch T, Wu D, Laugsch M, Schröder H, Höllt V, Schulz S (2003) Heterodimerization of substance P and mu-opioid receptors regulates receptor trafficking and resensitization. J Biol Chem 278: 51630-51637.
33. Smith NJ, Milligan G (2010) Allostery at G protein-coupled receptor homo- and heteromers: uncharted pharmacological landscapes. Pharmacol Rev 62: 701-725.
34. Han Y, Moreira IS, Urizar E, Weinstein H, Javitch JA (2009) Allosteric communication between protomers of dopamine class A GPCR dimers modulates activation. Nat Chem Biol 5: 688-695.
35. Ribeiro JA, Sebastião AM (1987) On the role, inactivation and origin of endogenous adenosine at the frog neuromuscular junction. J Physiol 384: 571-585.
36. Cunha RA, Vizi ES, Ribeiro JA, Sebastião AM (1996) Preferential release of ATP and its extracellular catabolism as a source of adenosine upon high- but not low-frequency stimulation of rat hippocampal slices. J Neurochem 67: 2180-2187.
37. Lovatt D, Xu Q, Liu W, Takano T, Smith NA, Schnermann J, Tieu K, Nedergaard M (2012) Neuronal adenosine release, and not astrocytic ATP release, mediates feedback inhibition of excitatory activity. Proc Natl Acad Sci U S A 109: 6265-6270.
38. Lee HU, Yamazaki Y, Tanaka KF, Furuya K, Sokabe M, Hida H, Takao K, Miyakawa T, Fujii S, Ikenaka K (2013) Increased astrocytic ATP release results in enhanced excitability of the hippocampus. Glia 61: 210-224.
39. Fields RD, Burnstock G (2006) Purinergic signalling in neuron-glia interactions. Nat Rev Neurosci 7: 423-436.
40. Klotz KN, Hessling J, Hegler J, Owman C, Kull B, Fredholm BB, Lohse MJ (1998) Comparative pharmacology of human adenosine receptor subtypes-characterization of stably transfected receptors in CHO cells. Naunyn Schmiedebergs Arch Pharmacol 357: 1-9.
41. Linden J, Thai T, Figler H, Jin X, Robeva AS (1999) Characterization of human A(2B) adenosine receptors: radioligand binding, western blotting, and coupling to G(q) in human embryonic kidney 293 cells and HMC-1 mast cells. Mol Pharmacol 56: 705-713.
42. Ongini E, Dionisotti S, Gessi S, Irenius E, Fredholm BB (1999) Comparison of CGS 15943, ZM 241385 and SCH 58261 as antagonists at human adenosine receptors. Naunyn-Schmiedeberg's Arch Pharmacol 359: 7-10.
43. Ji XD, Jacobson KA (1999) Use of the triazolotriazine [3H]ZM 241385 as a radioligand at recombinant human A2B adenosine receptors. Drug Des Discov 16: 217-226.